Key financial metrics and fundamentals for Transcode Therapeutics, Inc. (RNAZ).
Market Cap
$7.6M
P/E Ratio
-0.22
Forward P/E
--
EPS
$-37.80
Forward EPS
Dividend Yield
Beta
Revenue
52-Week Low
52-Week High